JARID1B downregulation results in the decrease of cell invasion capability. by Yung-Ting Kuo (736349)

Postnatal CDPPB treatment decreased [¹¹C]PBR accumulation in saline-exposed offspring, but not in offspring prenatally exposed to LPS. by Dany Arsenault (229311)

“…<p>Postnatal CDPPB treatment decreased the accumulation of [¹¹C]PBR in the olfactory bulb, cerebellum, hippocampus, striatum, hypothalamus and the whole brain of the offspring prenatally exposed to saline solution (A). …”

Intracellular ROS decrease mediated by TAT-fused protein delivery. by Cecilia L. Balaban (4424212)

Inhibition of F/P tyrosine kinase by imatinib in CEL patients decreased phosphorylation of JAK2, Stat3 and Stat5 in a time-dependent manner. by Bin Li (39349)

Role of RNA binding proteins and structure in modulating translation efficiency. by Lela Lackey (815515)

“…E) SHAPE reactivity for the nucleotides for the eCLIP QKI binding site including the putative binding motif of the RNA binding protein 5’-NACUAAY-N(1,20)-UAAY-3′ [<a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1009912#pgen.1009912.ref046" target="_blank">46</a>]. …”

The ATR IR signal decreases with decreasing dilutions of cells. by Allison L. Stelling (392086)

“…<p>Shown is a box plot for serial dilutions of a glioblastoma cell suspension. …”

The fold change and P value distribution of antibiotic resistance genes (ARGs) in B (composted pig manure) vs A (fresh pig manure). by Shuai Huang (60512)

Sildenafil treatment during recovery does not affect hyperoxia-induced decreases in alveolar counts. by Marta Perez (526067)

Twenty-four hour monitoring revealed increased interaction and decreased activity during daytime in <i>Cdkl5</i> -/Y mice. by Kosuke Okuda (5150393)

“…The genotype difference during the whole period was significant (p = 0.0012). (ii) Activity level (A.U.). The activity level of <i>Cdkl5</i> -/Y mice is significantly decreased compared to <i>Cdkl5</i> +/Y mice during daytime (p = 0.0004), but not in the nighttime (p = 0.1535). …”

SCS RNAi silencing results in growth phenotype and decreased ΔΨ_m in CMM_glc and CMM_gly medium. by Gergana Taleva (17131885)

Loss of <i>SLC4A11</i> expression in hCEnC leads to decreased cell barrier function. by Doug D. Chung (3611387)

Disruption of the interaction between AKIP 1A and PKAc decreases phosphorylation of p65 at serine 276 in the cytosol. by Charles C. King (156152)

Percentage of normal/intermediate/poor metabolizers, or persons with decreased or poor transporter function of SLCO1B1 or reduced expression of VKORC1, showing high proportions of... by Riccardo Proietti (15332861)

Reciprocal increase in 5mC and decrease in 5hmC at the pregnancy-associated gene clusters in placentas of obese compared to lean mothers. by Kohzoh Mitsuya (4521304)

“…<p>(A) Reciprocal increase in 5mC and decrease in 5hmC at the <i>GH-CSH</i> gene cluster on human chromosome 17q24. …”

Stroma decreases spheroid size by decreasing cell width. by Karen F. Chambers (224337)

Silencing JARID1B decreases epithelial to mesenchymal transition (EMT). by Yung-Ting Kuo (736349)

JNK inhibitor AS601245 significantly rescued the decrease in p-FOXO3a and attenuated FOXO3a translocation into nucleus after HI with no influence on p-Akt. by Deyuan Li (769599)

Data_Sheet_5_Identification and Analysis of Hub Genes in Diabetic Cardiomyopathy: Potential Role of Cytochrome P450 1A1 in Mitochondrial Metabolism and STZ-Induced Myocardial Dysfu... by Yinliang Chen (12266894)

“…Our RT-qPCR results confirmed that ventricular Cyp1a1 mRNA level was nearly 12-fold upregulated in DCM model compared to normal control, which was correlated with abnormal cardiac function in diabetic individuals. …”

Galiellalactone decreases the proportion of ALDH+ prostate cancer cells in vitro and the ALDH1A1 expression in vivo. by Rebecka Hellsten (348459)

“…<p>A. DU145 and LNCaP-IL6 cells were treated with galiellalactone (5–50 µM) for 24 h and subjected to ALDEFLUOR® assay. …”

Eltrombopag markedly decreases levels of ROS in MOLM14 cells. by Anna Kalota (7415)

“…B) Graphic presentation of ROS levels measured by flow cytometry in cells treated with E (5 μM) or DPI (25 μM), an inhibitor of NADPH oxidase known to decrease an intracellular level of ROS, or untreated (CTR) cells. …”